Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2023-08-16
2023-10-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Lymphedema on Breast Cancer Survivors
NCT00769821
Mobile Self-Management Training for Lymphedema Prevention
NCT07043140
Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery
NCT02073045
Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors
NCT07133087
COMPRESSION GARMENTS in BREAST CANCER-RELATED LYMPHEDEMA
NCT04832386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
developed lymphedema after breast cancer surgery
diagnosis of lymphedema
being diagnosed with secondary lymphedema in the upper extremity according to the International Lymphedema Association
breast cancer surgery
be diagnosed and undergo surgery
did not develop lymphedema after breast cancer surgery
breast cancer surgery
be diagnosed and undergo surgery
without a history of any cancer surgery
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
diagnosis of lymphedema
being diagnosed with secondary lymphedema in the upper extremity according to the International Lymphedema Association
breast cancer surgery
be diagnosed and undergo surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* being female,
* being aged 18-65 years,
* having undergone unilateral breast cancer surgery,
* being diagnosed with secondary lymphedema in the upper extremity according to the International Lymphedema Association
* not having any orthopedic disease that would prevent walking, and volunteering to participate in the study.
* without lymphedema were being female,
* being aged 18-65 years,
* having undergone unilateral breast cancer surgery, and volunteering to participate in the study.
* being female,
* being aged 18-65 years,
* having no history of cancer surgery, and volunteering to participate in the study.
Exclusion Criteria
* the presence of metastases, neurological, or orthopedic disorders;
* postural deformities, such as scoliosis and kyphosis;
* mental and cognitive disorders; or communication/cooperation problems
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Selcuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emine Cihan
Assist. Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Selcuk University
Konya, Selcuklu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/09.06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.